Actively Recruiting
Application of 18F-PSMA PET / CT Imaging in Prostate Specific Membrane Antigen Positive Tumor
Led by Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Updated on 2024-12-27
400
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In this study, Al18F-PSMA-BCH PET/CT will be performed in patients with prostate specific membrane antigen positive tumor, to evaluate the tumour detection efficacy of Al18F-PSMA-BCH PET/CT.
CONDITIONS
Official Title
Application of 18F-PSMA PET / CT Imaging in Prostate Specific Membrane Antigen Positive Tumor
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with suspected or confirmed PSMA positive-expressing tumors including prostate cancer, transitional epithelial carcinoma, colon carcinoma, adenoid cystadenocarcinoma, mesothelioma, hepatocellular carcinoma, cholangiocellular carcinoma, multiple myeloma, and others
- Age 18 years or older
- No gender restrictions
- Signed informed consent
- Willing and able to cooperate with all study procedures
You will not qualify if you...
- Serious neurological, gastrointestinal, cardiovascular, liver, kidney, blood, endocrine, respiratory, or immune deficiency diseases
- Claustrophobia
- Pregnant or breastfeeding women
- Received experimental drug or device within the past 1 month
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, Chaoyang, China, 100029
Actively Recruiting
Research Team
X
Xin Cheng, MD
CONTACT
G
Guozhu Hou, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here